6th Building Bridges Symposium: Epigenetics in Clinical and Translational Research
The Building Bridges symposia series is arranged to bridge clinical and basic/translational research and provide examples of how teams of investigators are working together towards a better understanding of the pathophysiology of disease and improved options for patient treatment and care.
The 6th Building Bridges symposium will highlight how epigenetics research can be leveraged to improve our understanding of health and disease. We set the stage by learning about the basics: What is epigenetics? How can studying epigenetics enable precision medicine? Then, with research-focused talks from clinical and translational researchers, we explore detailed examples of discovery, development, and application in the areas of 1) epigenomics, 2) cell differentiation in disease, and 3) epigenetic modifiers as drug targets. We close the symposium by engaging the public in the future societal applications of epigenetics research.
Join us for the latest insights into epigenetics and epigenomics research and a special outreach session to the general public!
Participants: The course is targeted both as an introduction to epigenetics as well as a demonstration of advancements in epigenetics research. As such, the events are open to the entire scientific community. Doctoral candidates wishing to learn about epigenetics, especially in relation to human health and disease, are encouraged to attend.
Organizers: Institute for Molecular Medicine Finland (FIMM), Centre for Genomic Regulation (CRG, Barcelona), EU-LIFE, University of Helsinki Doctoral Programmes in Biomedicine (DPBM), Clinical Research (KLTO), and Population Health (DocPop)